| Accession Number: | 0000899243-20-032786 |
| Date: | 2020-12-02 |
| Issuer: | INARI MEDICAL, INC. (NARI) |
| Original Submission Date: |
COOPERATIEVE GILDE HEALTHCARE IV U.A.
NEWTONLAAN 91 3584 BP
UTRECHT, P7
GILDE HEALTHCARE IV MANAGEMENT B.V.
NEWTONLAAN 91 3584 BP
UTRECHT, P7
GILDE HEALTHCARE HOLDING B.V.
NEWTONLAAN 91 3584 BP
UTRECHT, P7
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-12-02 | S | 3,839 | d | $63.81 | 7,495,296 | indirect | f2 | |
| COMMON STOCK | 2020-12-02 | S | 49,515 | d | $64.89 | 7,445,781 | indirect | f2 | |
| COMMON STOCK | 2020-12-02 | S | 4,102 | d | $65.50 | 7,441,679 | indirect | f2 | |
| COMMON STOCK | 2020-12-02 | S | 21,569 | d | $65.04 | 7,420,110 | indirect | f2 | |
| COMMON STOCK | 2020-12-03 | S | 1,620 | d | $65.03 | 7,418,490 | indirect | f2 | |
| COMMON STOCK | 2020-12-04 | S | 14,482 | d | $65.01 | 7,404,008 | indirect | f2 |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions ranging from $63.30 to $64.285, inclusive. the reporting persons undertake to provide to inari medical, inc. (the "issuer"), any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| f2 | all securities reported are held of record by cooperatieve gilde healthcare iv u.a. ("gilde"). gilde is managed by gilde healthcare iv management b.v. ("management"). management is owned by gilde healthcare holding b.v. ("holding"). each of management and holding may be deemed to have voting, investment and dispositive power with respect to the securities held by gilde. each of management and holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. |
| f3 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions ranging from $64.30 to $65.285, inclusive. the reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| f4 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions ranging from $65.305 to $66.25, inclusive. the reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| f5 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions ranging from $65.00 to $65.21, inclusive. the reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| f6 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions ranging from $65.00 to $65.165, inclusive. the reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| f7 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions ranging from $65.00 to $65.24, inclusive. the reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
